The introduction of new anticoagulation therapy in the European Union: The case of rivaroxaban

Aug-18

Pharmacoepidemiology

AUTHORS : Irene Bezemer, PHARMO Institute for Drug Outcomes Research, Van Deventerlaan 30-40, 3528 AE Utrecht, Netherlands – Email: irene.bezemer@pharmo.nl

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 27(S2):366

DOI : 10.1002/pds.4629

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more